deltatrials
Completed NA INTERVENTIONAL 1-arm NCT05466630

Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis (SpeSerTryp)

Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis in Côte d'Ivoire and Guinea

Sponsor: Foundation for Innovative New Diagnostics

Conditions Human African Trypanosomiasis Sleeping Sickness Trypanosoma Brucei Gambiense; Infection West African Sleeping Sickness
Interventions Immunologic laboratory tests Molecular laboratory tests Serological field test for HAT malaria rapid test
Updated 6 times since 2022 Last updated: Apr 4, 2024 Started: Jun 20, 2022 Primary completion: Aug 31, 2022 Completion: Aug 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Human African Trypanosomiasis and Sleeping Sickness and is currently completed. Foundation for Innovative New Diagnostics leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshotRecruiting~Apr 2023 – ~May 2024 · 13 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 9 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. May 2024 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  5. Apr 2023 — May 2024 [monthly]

    Recruiting NA

▶ Show 1 earlier version

  1. Sep 2022 — Apr 2023 [monthly]

    Recruiting NA

    First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Foundation for Innovative New Diagnostics
  • Institut Pasteur, Guinée
  • Institut Pierre Richet, Guinée
  • Institut de Recherche pour le Developpement
  • Programme National de lutte contre la THA, Guinée
  • Université Jean Lorougnon Guédé, Daloa
Data source: Institut de Recherche pour le Developpement

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations